| 1 |
A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells
Courtney M. Lappas, Jayson M. Rieger, Joel M Linden · The Journal of Immunology
Open access |
2005 |
386 |
| 2 |
Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária E. Čarná et al. · Biomedicines
Open access |
7 May 2021 |
323 |
| 3 |
Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease
Shreaya Chakroborty, Clark A. Briggs, Megan B. Miller et al. · PLoS ONE
Open access |
21 Dec 2012 |
142 |
| 4 |
The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
Jeffrey M. Wilson, William G. Ross, Oma N. Agbai et al. · The Journal of Immunology
Open access |
Apr 2009 |
136 |
| 5 |
Links Between Insulin Resistance, Adenosine A2B Receptors, and Inflammatory Markers in Mice and Humans
Robert A. Figler, Guoquan Wang, Susseela Srinivasan et al. · Diabetes
Open access |
21 Jan 2011 |
120 |
| 6 |
T-type calcium channels blockers as new tools in cancer therapies
Barbara Dziegielewska, Lloyd S. Gray, Jaroslaw Dziegielewski · Pflügers Archiv - European Journal of Physiology
|
21 Jan 2014 |
111 |
| 7 |
A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury
Yuan‐Ji Day, Yuesheng Li, Jayson M. Rieger et al. · The Journal of Immunology
|
Apr 2005 |
95 |
| 8 |
Inhibition of T-type calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells
Nicholas C.K. Valerie, Barbara Dziegielewska, Amol S. Hosing et al. · Biochemical Pharmacology
|
31 Dec 2012 |
93 |
| 9 |
A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence
Mohammad Samiul Alam, Courtney C. Kurtz, Jeffrey M. Wilson et al. · Mucosal Immunology
Open access |
4 Mar 2009 |
78 |
| 10 |
RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord
David G. Brohawn, Laura C. O’Brien, James P. Bennett · PLoS ONE
Open access |
3 Aug 2016 |
76 |
| 11 |
Effect of Novel A2AAdenosine Receptor Agonist ATL 313 onClostridium difficileToxin A-Induced Murine Ileal Enteritis
Ingrid Chaves Cavalcante, M. V. Castro, A. R. F. Barreto et al. · Infection and Immunity
|
18 Apr 2006 |
74 |
| 12 |
Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels
Yugesh Kharel, Emily A. Morris, Molly D. Congdon et al. · Journal of Pharmacology and Experimental Therapeutics
Open access |
5 Aug 2015 |
67 |
| 13 |
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model
Stephen Thomas Keir, Henry S. Friedman, David A. Reardon et al. · Journal of Neuro-Oncology
|
19 Oct 2012 |
62 |
| 14 |
Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow–derived cells or deletion of the A2A receptor on non-bone marrow–derived cells
Y. Li, Rod J. Oskouian, Yuan‐Ji Day et al. · Neuroscience
|
2006 |
53 |
| 15 |
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
IsaacG Onyango, JamesP Bennett, Gorazd Bernard Stokin · Neural Regeneration Research
Open access |
2021 |
47 |
| 16 |
RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer’s Disease and Parkinson’s Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia
James P. Bennett, Paula M. Keeney, David G. Brohawn · Frontiers in Neuroscience
Open access |
28 Mar 2019 |
42 |
| 17 |
Alzheimer’s and Parkinson’s brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1α protein and mtRNA stabilizing protein LRPPRC (LRP130)
James P. Bennett, Paula M. Keeney · Mitochondrion
|
Jun 2020 |
37 |
| 18 |
Adenosine A2A Analogue Improves Neurologic Outcome after Spinal Cord Trauma in the Rabbit
David C. Cassada, Curtis G. Tribble, Jeffrey S. Young et al. · The Journal of Trauma: Injury, Infection, and Critical Care
|
Aug 2002 |
35 |
| 19 |
In Vivo Molecular Imaging Biomarkers: Clinical Pharmacology’s new “PET”?
R. Nutt, L J Vento, Maya Ridinger · Clinical Pharmacology & Therapeutics
|
15 May 2007 |
28 |
| 20 |
Sphingosine kinase inhibitors: a review of patent literature (2006-2015)
Kevin R. Lynch, Steven B. Thorpe, Webster L. Santos · Expert Opinion on Therapeutic Patents
Open access |
19 Aug 2016 |
27 |
| 21 |
Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer’s Disease
James P. Bennett, Jeffrey Murray Burns, Paul Welch et al. · Journal of Alzheimer s Disease
Open access |
11 Dec 2015 |
27 |
| 22 |
Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case Study
Andrew J. Krouse, Lloyd A. Gray, Timothy L. Macdonald et al. · Assay and Drug Development Technologies
|
Dec 2015 |
27 |
| 23 |
Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures
James P. Bennett, Isaac G. Onyango · Biomedicines
Open access |
22 Feb 2021 |
26 |
| 24 |
Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis
James P. Bennett, Laura C. O’Brien, David G. Brohawn · Biochemical Pharmacology
|
4 Aug 2016 |
24 |
| 25 |
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Isaac G. Onyango, James P. Bennett, Gorazd Bernard Stokin · Current Alzheimer Research
Open access |
Sep 2021 |
22 |
| 26 |
Exploiting MCF-7 Cells’ Calcium Dependence with Interlaced Therapy
Jonathan E. Pottle, Chengrong Sun, Lloyd S. Gray et al. · Journal of Cancer Therapy
Open access |
2013 |
21 |
| 27 |
Platelet P2 receptors: from curiosity to clinical targets
Noel J. Cusack, Susanna M.O. Hourani · Journal of the Autonomic Nervous System
|
Jul 2000 |
21 |
| 28 |
RNA-seq analyses reveal that cervical spinal cords and anterior motor neurons from amyotrophic lateral sclerosis subjects show reduced expression of mitochondrial DNA-encoded respiratory genes, and rhTFAM may correct this respiratory deficiency
Amy C. Ladd, David G. Brohawn, Ravindar R. Thomas et al. · Brain Research
|
13 May 2017 |
20 |
| 29 |
Pharmacology of 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470), a novel, short-acting adenosine A2A receptor agonist that produces selective coronary vasodilation
Pauline L. Martin, Richard J. Barrett, Joel M Linden et al. · Drug Development Research
|
Apr 1997 |
19 |
| 30 |
RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer’s and Parkinson’s Diseases
James P. Bennett, Paula M. Keeney · Journal of Alzheimer s Disease Reports
Open access |
6 Mar 2018 |
18 |
| 31 |
Effects of 2-methylthioadenosine 5?-?,?-methylenetriphosphonate and 2-ethylthioadenosine 5?-monophosphate on human platelet activation induced by adenosine 5?-diphosphate
Susanna M.O. Hourani, Laurence A. Welford, Noel J. Cusack · Drug Development Research
|
May 1996 |
17 |
| 32 |
Early adenosine receptor activation ameliorates spinal cord reperfusion injury
Thomas Brett Reece, Curtis G. Tribble, David O. Okonkwo et al. · Journal of Cardiovascular Medicine
Open access |
Apr 2008 |
17 |
| 33 |
Alzheimer’s Disease Frontal Cortex Mitochondria Show a Loss of Individual Respiratory Proteins but Preservation of Respiratory Supercomplexes
Paula M. Kenney, James P. Bennett · International Journal of Alzheimer s Disease
Open access |
5 Mar 2019 |
12 |
| 34 |
Micro RNA’s (mirna’s) may help explain expression of multiple genes in Alzheimer’s Frontal Cortex
James P. Bennett, Paula M. Keeney · Journal of Systems and Integrative Neuroscience
Open access |
2017 |
9 |
| 35 |
Medical hypothesis: Neurodegenerative diseases arise from oxidative damage to electron tunneling proteins in mitochondria
James P. Bennett · Medical Hypotheses
Open access |
28 Mar 2019 |
8 |
| 36 |
Pharmacology and toxicology of the A2A-adenosine receptor agonist 2- [(cyclohexylmethylene)hydrazino]adenosine (MRE-0470) in the rat
Pauline L. Martin, Richard J. Barrett, Alex M. Sykes et al. · Drug Development Research
|
Oct 1997 |
5 |
| 37 |
Nutraceuticals: Miracle or Meme?
Maya Ridinger · Clinical Pharmacology & Therapeutics
|
13 Sep 2007 |
5 |
| 38 |
Laser-captured spinal cord motorneurons from ALS subjects show increased gene expression in vacuolar ATPase networks
Amy C. Ladd, David G. Brohawn, James P. Bennett · Journal of Systems and Integrative Neuroscience
Open access |
2017 |
3 |
| 39 |
Conjugation of nitrated acetaminophen to Der p1 amplifies peripheral blood monocyte response to Der p1
Ryan G. Thomas, Brenda M. Rivera Reyes, Benjamin M Gaston et al. · PLoS ONE
Open access |
11 Dec 2017 |
3 |
| 40 |
Presentation of ichthyosis after substrate reduction therapy in Gaucher type 1
Jack Herbster, Carlos Enrique Prada, Carly A. Rasmussen et al. · American Journal of Medical Genetics Part A
Open access |
5 Aug 2024 |
1 |
| 41 |
A Spotlight on Microneurotrophins: The Future of Amyotrophic Lateral Sclerosis Treatment?
James P. Bennett · Neurodegenerative Disease Management
Open access |
Jun 2015 |
1 |
| 42 |
« ENTRE DETERMINISME PSYCHOLOGIQUE ET IMPERATIF DE JUSTICE : ANALYSE CRITIQUE DE L'EFFICACITE PREVENTIVE EN DROIT PENAL INTERNATIONAL »
Paulin Nyengo Olonge · Zenodo (CERN European Organization for Nuclear Research)
PreprintOpen access |
20 Apr 2026 |
0 |
| 43 |
Regulation of T-Type Ca2+ Channels in Cancer Cell Cycle
Jonathan E. Pottle, Lloyd S. Gray
Book chapter |
18 Nov 2014 |
0 |
| 44 |
80. Long-duration reversal of neuropathic pain via sustained release of spinal interleukin-10 is mediated by adenosine 2A receptor activation
Lisa Carole Loram, Evan M. Sloane, Jackie Harrison et al. · Brain Behavior and Immunity
|
Jul 2009 |
0 |
| 45 |
Is the Dx for Welfare Rx?
Maya Ridinger · Clinical Pharmacology & Therapeutics
|
16 Apr 2007 |
0 |